Wilkins Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7M Sell
246,748
-3,608
-1% -$417K 4.25% 2
2025
Q4
$26.4M Sell
250,356
-16,351
-6% -$1.53M 3.84% 2
2025
Q3
$22.4M Buy
266,707
+3,131
+1% +$258K 3.17% 6
2025
Q2
$20.9M Buy
263,576
+11,019
+4% +$876K 2.95% 9
2025
Q1
$22.7M Buy
252,557
+9,245
+4% +$863K 3.25% 6
2024
Q4
$24.2M Buy
243,312
+830
+0.3% +$85.6K 3.5% 3
2024
Q3
$27.5M Sell
242,482
-1,884
-0.8% -$224K 3.81% 2
2024
Q2
$30.3M Sell
244,366
-1,215
-0.5% -$157K 4.51% 1
2024
Q1
$32.4M Buy
245,581
+75,349
+44% +$9.29M 4.73% 1
2023
Q4
$18.6M Sell
170,232
-420
-0.2% -$43.6K 4.53% 1
2023
Q3
$17.6M Sell
170,652
-3,820
-2% -$412K 4.75% 1
2023
Q2
$20.1M Sell
174,472
-8,846
-5% -$1M 5.26% 1
2023
Q1
$19.5M Sell
183,318
-7,843
-4% -$847K 5.12% 1
2022
Q4
$21.2M Sell
191,161
-8,863
-4% -$906K 5.58% 1
2022
Q3
$17.2M Sell
200,024
-2,695
-1% -$241K 5.04% 1
2022
Q2
$18.5M Sell
202,719
-3,825
-2% -$339K 4.9% 2
2022
Q1
$16.9M Buy
206,544
+937
+0.5% +$73.9K 3.82% 2
2021
Q4
$15.8M Buy
205,607
+2,475
+1% +$197K 3.48% 4
2021
Q3
$15.3M Buy
203,132
+3,575
+2% +$272K 3.73% 3
2021
Q2
$15.5M Sell
199,557
-7,860
-4% -$585K 3.82% 2
2021
Q1
$15.3M Buy
207,417
+875
+0.4% +$64.5K 3.95% 3
2020
Q4
$16.1M Sell
206,542
-6,576
-3% -$503K 4.46% 2
2020
Q3
$16.9M Buy
213,118
+1,231
+0.6% +$96.4K 5.03% 2
2020
Q2
$15.6M Buy
211,887
+865
+0.4% +$65.1K 4.95% 2
2020
Q1
$15.5M Sell
211,022
-4,853
-2% -$381K 5.65% 2
2019
Q4
$18.7M Sell
215,875
-1,027
-0.5% -$84.4K 5.32% 1
2019
Q3
$17.4M Sell
216,902
-760
-0.3% -$60.9K 5.24% 1
2019
Q2
$17.4M Sell
217,662
-1,598
-0.7% -$122K 5.22% 1
2019
Q1
$17.4M Sell
219,260
-4,627
-2% -$346K 5.26% 1
2018
Q4
$16.3M Sell
223,887
-1,370
-0.6% -$96.7K 5.41% 1
2018
Q3
$15.2M Sell
225,257
-1,441
-0.6% -$91.8K 4.56% 1
2018
Q2
$13.1M Sell
226,698
-943
-0.4% -$53.2K 4.13% 4
2018
Q1
$11.8M Buy
227,641
+2,672
+1% +$144K 3.74% 6
2017
Q4
$12.1M Buy
224,969
+876
+0.4% +$48.6K 3.61% 6
2017
Q3
$13.7M Buy
224,093
+2,075
+0.9% +$126K 4.17% 2
2017
Q2
$13.6M Buy
222,018
+1,122
+0.5% +$68.3K 4.32% 1
2017
Q1
$13.4M Sell
220,896
-2,044
-0.9% -$124K 4.29% 1
2016
Q4
$12.5M Buy
222,940
+6,733
+3% +$394K 3.99% 1
2016
Q3
$12.9M Buy
216,207
+53
+0% +$3.1K 4.32% 2
2016
Q2
$11.9M Buy
216,154
+1,677
+0.8% +$89.3K 4.02% 2
2016
Q1
$10.8M Buy
214,477
+9,295
+5% +$455K 3.97% 1
2015
Q4
$10.3M Sell
205,182
-4,899
-2% -$247K 3.88% 2
2015
Q3
$9.9M Buy
210,081
+1,782
+0.9% +$94.7K 3.79% 2
2015
Q2
$11.3M Buy
208,299
+786
+0.4% +$44.1K 4.12% 1
2015
Q1
$11.4M Sell
207,513
-53
-0% -$3K 4.02% 1
2014
Q4
$11.2M Buy
207,566
+1,467
+0.7% +$81.7K 3.91% 1
2014
Q3
$11.7M Sell
206,099
-838
-0.4% -$47.1K 4.16% 1
2014
Q2
$11.4M Buy
206,937
+1,179
+0.6% +$64.3K 4.03% 1
2014
Q1
$11.1M Buy
205,758
+838
+0.4% +$43.4K 4.11% 1
2013
Q4
$9.79M Buy
204,920
+4,329
+2% +$198K 4.06% 1
2013
Q3
$9.11M Sell
200,591
-2,804
-1% -$128K 4.16% 1
2013
Q2
$9.02M Buy
+203,395
New +$9.08M 4.18% 1

Other funds holding MRK

Wilkins Investment Counsel's MRK Position: Q1 2026 in Review

Wilkins Investment Counsel reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $417K and leaving 246,748 shares worth $29.7M. The position accounts for 4.25% of the portfolio, ranked #2.

Wilkins Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.4M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wilkins Investment Counsel held 246,748 shares of Merck worth $29.7M as of Q1 2026.
  • Wilkins Investment Counsel sold 3,608 Merck shares in Q1 2026, an estimated $417K.
  • Merck made up 4.25% of Wilkins Investment Counsel's portfolio in Q1 2026, its #2 holding.
  • Wilkins Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Wilkins Investment Counsel's Merck position peaked at $32.4M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.